Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists

Latest Ally Bridge Group (NY) LLC Stock Portfolio

$167Million

Equity Portfolio Value
Last Reported on: 14 Feb, 2024

About Ally Bridge Group (NY) LLC and it’s 13F Hedge Fund Stock Holdings

Ally Bridge Group (NY) LLC is a hedge fund based in New York, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $146.7 Millions. In it's latest 13F Holdings report, Ally Bridge Group (NY) LLC reported an equity portfolio of $85.2 Millions as of 30 Sep, 2023.

The top stock holdings of Ally Bridge Group (NY) LLC are MLTX, XENE, ITCI. The fund has invested 12.2% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 10.7% of portfolio in XENON PHARMACEUTICALS INC.

The fund managers got completely rid off REATA PHARMACEUTICALS INC-A (RETA), VERONA PHARMA PLC - ADR and VIRIDIAN THERAPEUTICS INC (VRDN) stocks. They significantly reduced their stock positions in PRAXIS PRECISION MEDICINES I (PRAX) and BLACK DIAMOND THERAPEUTICS I (BDTX). Ally Bridge Group (NY) LLC opened new stock positions in INTRA-CELLULAR THERAPIES INC (ITCI), AXSOME THERAPEUTICS INC (AXSM) and APELLIS PHARMACEUTICALS INC (APLS). The fund showed a lot of confidence in some stocks as they added substantially to MOONLAKE IMMUNOTHERAPEUTICS (MLTX), JASPER THERAPEUTICS INC (JSPR) and MERUS NV (MRUS).

New Buys

Ticker$ Bought
ARGENX SE - ADR13,315,000
SOLENO THERAPEUTICS INC12,475,500
CYMABAY THERAPEUTICS INC11,572,300
OLEMA PHARMACEUTICALS INC9,246,260
ALPINE IMMUNE SCIENCES INC6,809,580
AMBRX BIOPHARMA INC5,487,850
AVADEL PHARMACEUTICALS-ADR4,900,150
HARPOON THERAPEUTICS INC4,870,910

New stocks bought by Ally Bridge Group (NY) LLC

Additions to existing portfolio by Ally Bridge Group (NY) LLC

Reductions

Ticker% Reduced
MOONLAKE IMMUNOTHERAPEUTICS-21.64
INTRA-CELLULAR THERAPIES INC-19.23
APELLIS PHARMACEUTICALS INC-17.49
XENON PHARMACEUTICALS INC-9.36
AXSOME THERAPEUTICS INC-8.8
COMPASS THERAPEUTICS INC-8.75

Ally Bridge Group (NY) LLC reduced stake in above stock

Sold off

Ticker$ Sold
PRAXIS PRECISION MEDICINES I-1,806,390
ARDELYX INC-3,595,930
BLACK DIAMOND THERAPEUTICS I-1,820,130
AMBRX BIOPHARMA INC-3,232,520
CYTOKINETICS INC-6,580,830
MIRATI THERAPEUTICS INC-3,061,530

Ally Bridge Group (NY) LLC got rid off the above stocks

Current Stock Holdings of Ally Bridge Group (NY) LLC

Last Reported on: 14 Feb, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
ALPNALPINE IMMUNE SCIENCES INC4.06357,2716,809,580NEW
AMAMAMBRX BIOPHARMA INC3.27385,3835,487,850NEW
AMAMAMBRX BIOPHARMA INC0.000.000.00SOLD OFF-100
AMLXAMYLYX PHARMACEUTICALS INC2.42275,7734,059,380ADDED1.13
APLSAPELLIS PHARMACEUTICALS INC5.35150,0008,979,000REDUCED-17.49
ARDXARDELYX INC0.000.000.00SOLD OFF-100
ARGXARGENX SE - ADR7.9335,00013,315,000NEW
AVDLAVADEL PHARMACEUTICALS-ADR2.92347,0364,900,150NEW
AXSMAXSOME THERAPEUTICS INC4.78100,8628,027,610REDUCED-8.8
BDTXBLACK DIAMOND THERAPEUTICS I0.000.000.00SOLD OFF-100
CBAYCYMABAY THERAPEUTICS INC6.89489,93811,572,300NEW
CMPXCOMPASS THERAPEUTICS INC0.78834,6301,302,020REDUCED-8.75
CNTXCONTEXT THERAPEUTICS INC0.49725,951820,325UNCHANGED0.00
CYTKCYTOKINETICS INC0.000.000.00SOLD OFF-100
GERNGERON CORP3.742,971,6406,270,160ADDED33.76
HARPHARPOON THERAPEUTICS INC2.90428,4004,870,910NEW
ITCIINTRA-CELLULAR THERAPIES INC6.03141,34810,123,300REDUCED-19.23
JSPRJASPER THERAPEUTICS INC17.203,659,26028,871,500ADDED16.38
MDVLMEDAVAIL HOLDINGS INC0.32117,897529,358UNCHANGED0.00
MLTXMOONLAKE IMMUNOTHERAPEUTICS5.16143,4798,664,700REDUCED-21.64
MRTXMIRATI THERAPEUTICS INC0.000.000.00SOLD OFF-100
MRUSMERUS NV4.50274,9237,560,380ADDED24.18
OLMAOLEMA PHARMACEUTICALS INC5.51659,0359,246,260NEW
PMNPROMIS NEUROSCIENCES INC0.731,066,6701,226,680ADDED100
PRAXPRAXIS PRECISION MEDICINES I0.9470,4241,569,050NEW
PRAXPRAXIS PRECISION MEDICINES I0.000.000.00SOLD OFF-100
SLNOSOLENO THERAPEUTICS INC7.43309,95012,475,500NEW
XENEXENON PHARMACEUTICALS INC6.64241,96111,144,700REDUCED-9.36